Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million - Bioretec Ltd.
Summary
THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.Bioretec Ltd ("Bioretec" or the "Company"), a pioneer in biodegradable orthopedic implants, hereby announces the result of the offering of new shares (the "Placing Shares") in a private placement to institutional and other qualified investors (the "Placing"). The success of this offering not only strengthens our financial position but also enables us to accelerate key initiatives in commercialization of our RemeOs Trauma Screw and development of our future product pipeline. Together, we are poised to seize the opportunities ahead and achieve long-term success", comments Alan Donze, the CEO of the Company.Danske Bank A/S, Finland Branch is acting as the sole bookrunner of the Placing. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. Subject to certain limited exceptions, the securities referred to in this release are being offered and sold only outside the United States.Danske Bank acts only for and on behalf of the Company in connection with the Placing.